Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1989-06-14
1990-09-04
Lipovsky, Joseph A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514182, A61K 3156
Patent
active
049544888
ABSTRACT:
The present invention is directed to a method for the treatment of hyperaldosteronism and related disorders which comprises administering to an appropriate patient an appropriate 17.beta.-cyclopropylaminoandrostene.
REFERENCES:
patent: 3639598 (1972-02-01), Klimstra
patent: 4891367 (1990-01-01), Angelastro et al.
Davis, et al., J. Chem. Soc., C, Org., 19, 1688 (1966).
B. J. Taylor, M. S. Thesis, Massachusetts Institute of Technology, 1985, pp. 2, 24-26 (Incomplete), Abstract and Figures.
Kolando John J.
Lipovsky Joseph A.
Merrell Dow Pharmaceuticals Inc.
LandOfFree
Method of treating hyperaldosteronism using 17.beta.-cyclopropyl does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating hyperaldosteronism using 17.beta.-cyclopropyl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating hyperaldosteronism using 17.beta.-cyclopropyl will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-442084